Twitter is rolling out a subscription service, starting in Canada and Australia, that offers perks like an undo button for subscribers.
The “Twitter Blue” subscription service will offer features that users have long asked for — but still no edit button. It includes bookmark folders for organizing saved content; an “Undo tweet" feature that gives users 30 seconds to cancel a sent tweet before it appears; a “reader mode" that makes threaded tweets easier to read; and customizable app icons and color themes.
Subscribers will also get dedicated customer support, meaning issues they report could get attention faster than other users.
The subscription costs 3.50 Canadian dollars ($2.89) a month and 4.50 Australian dollars ($3.45). There's no timeline for rolling out the service in other countries.
Twitter has been adding new features to attract new users. The social media site has nearly 200 million daily users, fewer than other social media networks. Facebook had 1.88 billion daily users on average in March 2021. Snapchat, meanwhile, had 280 million average daily active users in the first quarter.
Twitter shares closed Thursday down 15 cents at $57.01.
Conditions have been mostly nice for travelers flying ahead of and on Christmas Day, but some naughty disruptions plagued those flying with Southwest Airlines again this year.
Gift cards make great stocking stuffers — just as long as you don't stuff them in a drawer and forget about them after the holidays.
Big Business This Week is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.
Supermarket chain Ralphs is facing a new lawsuit from the state of California.
Shake Shack is giving out free fried chicken sandwiches, bacon cheese fries and milkshakes nationwide.
The IRS is announcing a voluntary disclosure program.
Lionsgate announced its studio division is going to spin off in a merger with Screaming Eagle Acquisition Corp., which is a special purpose acquisition company.
A new report suggests that it's getting more difficult for an average American to afford a home.
The Food and Drug Administration warned consumers about a copycat version of the diabetes drug Ozempic.
